The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...
MEN with aggressive prostate cancer could benefit from a new drug combination that slows cancer growth, scientists say.
The Brighterside of News on MSN
New drug combination stops prostate cancer growth in phase 3 clinical trial
An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...
News Medical on MSN
Novel drug combination offers hope for men with advanced prostate cancer
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...
By Stephen Beech Men with advanced prostate cancer have been offered fresh hope thanks to a "promising" new drug combination.
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...
Until about 15 years ago, most men diagnosed with prostate cancer — no matter how aggressive — underwent surgery or radiation ...
News-Medical.Net on MSN
Five-session SBRT reduces side effects in intermediate-risk prostate cancer
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Thousands of men with incurable prostate cancer could live longer thanks to a breakthrough study that found combining two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results